Loading...

PTCT PTC THERAPEUTICS INC Product Launches 8-K Filing

PTC

PTCT

PTC THERAPEUTICS INC

(PTCT)

2026 8-K

Financial Results Update

Positive Study Results

Board Appointment

Financial Results Report

Drug Application Withdrawal

Financial Results Update

Royalty Sale Agreement

Financial Results Report

FDA Response Letter

Merger of Equals

Financial Statements

New Product Launches

Financial Statements

Investor Meetings

Milestone Payment

Earnings Report

Earnings Report

Earnings Update

New Partnership

Earnings Report

Earnings Report

Filing Letter with Quantita...

Filing with Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Filing with Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Filing with Quantitative Data

Quantitative Data

Quantitative Data

Quantitative Data

Management Change

Quantitative Data

Filing with Quantitative Data

External Links:

On April 28, 2026, PTC Therapeutics, Inc. announced positive topline results from a 24-month interim analysis of the PIVOT-HD long-term study of votoplam. A virtual presentation on these results is scheduled for the same day at 4:30 PM ET.

AI Assistant

PTC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.